eISSN: 2299-0054
ISSN: 1895-4588
Videosurgery and Other Miniinvasive Techniques
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2013
vol. 8
 
Share:
Share:
Case report

Rapid onset anterior segment complication following diode laser photocoagulation for retinopathy of prematurity: a case report

Lidia Puchalska-Niedbał
,
Monika Modrzejewska
,
Urszula Kulik

Videosurgery Miniinv 2013; 8 (1): 90-93
Online publish date: 2012/10/30
Article file
- Rapid onset anterior.pdf  [0.16 MB]
Get citation
 
PlumX metrics:
 

Introduction

Retinopathy of prematurity (ROP) is an eye disorder that affects infants born prematurely [1]. Untreated, it may lead to significant vision loss already in early childhood and lifelong severe consequences including blindness [2]. Infants with ROP are considered to be at higher risk for developing certain eye problems later in life; e.g. retinal detachment, myopia, glaucoma and strabismus frequently occur.

Among the most effective, proven treatments for ROP are laser therapy and cryotherapy [3]. Relatively atraumatic, easier to administer laser photocoagulation of the avascular retina compared with cryotherapy of prematurity is associated with a lower risk of retinal detachment [4], less myopia [4, 5] less postoperative eyelid oedema and conjunctival chemosis [6]. However, this type of treatment is not without potentially serious complications.

Furthermore, it has been suggested that intensive laser photocoagulation of the avascular retina increases the risk of corneal burns, band keratopathy, hyphaemia, glaucoma, cataract, hypotony as well as necrosis of the anterior segment of the eye [7-9]. The severity of the ocular injury is dependent on the wavelength of the incident light. Thermal injury can lead to anterior eye segment ischaemia, assuming that the energy of the laser beam acting on this region of the globe can be absorbed, which can lead to destruction of the major nutrient branches for this eyeball area, i.e. posterior ciliary arteries [10].

As the literature is mainly dominated by detailed accounts of the physical presentation of ROP cases, this report emphasizes the need for eye status control in case of complications that might occur after laser therapy for ROP as well as in order to extend the knowledge on the long-term visual organ condition.

This case study presents the ocular complication arising after diode-laser photocoagulation described as progressive hypertrophy of the conjunctiva. To the best of our knowledge, there has been no such report in the literature before.

Case report

A 1210 γ birth weight infant, born at 28 weeks’ gestation, was screened for ROP at 33 weeks’ postconceptual age (PCA). The fundoscopy visualized by Ret-Cam II method (Clarity Medical Systems) showed bilateral stage 3 of threshold ROP with definitely more expressed changes in the right eye, defined by the International Committee for the Classification of Retinopathy of Prematurity [11]. Ultrasonography (US-3300 EchoScan ultrasonic B- scan with 10-MHz sector probe equipment – Nidek Co. Japan) additionally confirmed the diagnosis. Intraocular pressure measured by I-care PRO Tonometer (Icare Finland Oy) was within the normal range (15.9 mm Hg).

Transpupillary diode-laser photocoagulation (diode laser Iris Medical, OcuLight S), considered as the technique of choice [12], performed by indirect ophthalmoscope and +28.00 Dptr lens for stereoscopic fundus visualization, was implemented in both eyes, under general inhalatory anaesthesia, after tripled mydriasis with 1% sol. tropicamide and 2.5% sol. phenylephrine hydrochloride administered to the conjunctival sac at 10 min apart. Treatment intensity ranged from 200 mW to 350 mW, with 3525 applications to the right eye and 2501 to the left eye and 100 ms duration. It was performed by one and the same ophthalmologist, experienced in this type of procedure among premature infants.

The first ophthalmological follow-up examination, undertaken after 5 days, revealed that the left eye responded favorably to the laser therapy, but clinically significant abnormalities were seen at the anterior segment in the right eye. Initially on biomicroscopy (hand slit lamp), then by observing, in the anterior eye segment advanced severe conjunctival hyperaemia, and its oedema causing partial coverage of the cornea was recorded. Topical therapy with anti-inflammatory eye medication, such as combination of dexamethasone 0.1% and diclofenac, did not result in a desirable outcome. Gradually, on the following examinations progressive and severe oedema augmentation, hypertrophy of the conjunctiva, hyperaemia and complete coverage of the cornea preventing light perception by the visual organ was observed (Photo 1). Additionally, skin lesions at the right periocular skin were assessed on examination. Based on the patient’s medical records, after dermatological consultation they were classified as atopic dermatitis (AD).

In this case, surgical treatment was required due to expanding conjunctival lesions, in order to limit the adverse effects of laser panphotocoagulation. Performed surgery consisted of excision of the excess conjunctiva (with a circular scar) covering the cornea up to the corneal limbus (Photo 2).

Histopathological examination revealed that fibrous tissue similar to a hypertrophic scar has been a major component of the hypertrophied conjunctiva. Subsequent follow-up examinations showed that the eye had a beneficial anatomical result from this therapy, allowing an easy fundus examination revealing retinal attachment, and regressed ROP with no signs of an inflammatory or ischaemic processes.

Discussion

Complications after diode laser treatment for ROP that may lead to many pathological changes both in the anterior and posterior segment of the eye have been previously reported [13-16]. We present an uncommon, undesired outcome in the right eye in the form of massive oedema and hyperaemia of the conjunctiva, along with its sudden hypertrophy that developed shortly after retinal transpupillary diode laser panphotocoagulation.

The lesion initially did not exceed the margin of the pupil, but it gradually expanded, which led to massive oedema of the conjunctiva and a completely covered cornea, resulting in lack of light access to the eye, which might slow down in this period proper vision formation and could have an adverse effect on further development of binocular vision. Conservative treatment of this complication in the form of topical anti-inflammatory drops administration did not bring the expected results.

In an attempt to reinstate function and structural integrity of the fellow eye as well as to prevent the sight-threatening proliferation, surgical excision of the excess conjunctiva up to the corneal limbus was conducted, yielding a favorable therapeutic outcome.

Interestingly, according to available internet resources the presented complication associated with diode laser therapy seems to be the only case reported so far. Frequently mentioned in the medical literature, as well as observed in our ward, undesired outcomes of diode laser therapy involving infantile eyes include subconjunctival haemorrhages, conjunctival thickening in areas with surgical hook oppression (used for scleral bulking) as well as temporary, mild oedema of the conjunctiva [3]. In addition, it should be mentioned that in those preterm infants with extremely low birth weight whose tissues are thin and immature, transpupillary laser photocoagulation may be associated with increased risk of corneal opacities formation or corneal injuries in the course of their increased susceptibility to overheating or secondary to laser therapy ischaemia.

Based on our experience in the field of available treatments for ROP, even higher doses of laser applications than used by the authors have not previously caused such massive side effects as presented. Hence, we can assume that this complication could be the result of overheating of the thin conjunctiva tissue. Therefore, it is important while implementing diode laser treatment in a group of extremely low-weight, and low-weight premature infants to consider the number of laser burns used per eye, power of the laser wavelength and duration of the laser application procedure, as eyes of infants born prematurely due to high immaturity are prone to thermal injury [15, 17, 18]. It is likely that a higher amount of energy generated during the procedure contributed to tissues overheating, which might be a cause of conjunctiva hypertrophy due to its thermal injury [19, 20]. This is perhaps the origin of the hypertrophy that we have observed in the eye where the number of laser applications was greater. It is possible that in preterm infants, after transpupillary laser photocoagulation, thermal damage to the posterior ciliary arteries could lead to ischaemia, the consequence of which could be stimulation of conjunctival epithelial cell proliferation [21]. Coexistence of dermatological findings in the region of the affected eye may support the hypothesis that immunological background is an additional factor that might predispose to progression of this ocular complication in children after diode laser therapy for ROP.

It should be emphasized that our prompt surgical treatment (excision of the excess conjunctiva) has been shown to be effective; therefore it could be suggested as a therapeutic approach in similar cases. In summary, in premature infants it is recommended to start follow-ups after diode laser treatment as early as possible, in order to detect any complications of the anterior segment of the eye. Such action in newborns is extremely significant, because omission of this procedure may result in irreversible impairment of vision, formation of which is attributed to the first 2 years of life.

References

 1. Hunter DG, Mukai S. Retinopathy of prematurity: pathogenesis, diagnosis, and treatment. Int Ophthalmol Clin 1992; 32: 163-84.

 2. Modrzejewska M, Grzesiak W, Karczewicz D, et al. Refractive status and ocular axial length in preterm infants without retinopathy of prematurity with regard to birth weight and gestational age. J Perinat Med 2010; 38: 327-31.

 3. Modrzejewska M, Tomala E, Karczewicz D, et al. The results of panphotocoagulation laser treatment in retinopathy of prematurity in the West Pomeranian Region in 2003-2005 years. Klin Oczna 2006; 108: 409-12.

 4. Connolly BP, McNamara JA, Sharma S, et al. A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity. Ophthalmology 1998; 105: 1628-31.

 5. Algawi K, Goggin M, O’Keefe M. Refractive outcome following diode laser versus cryotherapy for eyes with retinopathy of prematurity. Br J Ophthalmol 1994; 78: 612-4.

 6. Hunter DG, Repka MX. Diode laser photocoagulation for threshold retinopathy of prematurity. A randomized study. Ophthalmology 1993; 100: 238-44.

 7. Jost BF, Olk RJ, Patz A, et al. Anterior segment ischaemia following laser photocoagulation in a patient with systemic lupus erythematosus. Br J Ophthalmol 1988; 72: 11-6.

 8. Cartwright MJ, Blair CJ, Combs JL, et al. Anterior segment ischemia: a complication of retinal detachment repair in a patient with sickle cell trait. Ann Ophthalmol 1990; 22: 333-4.

 9. Lee BL, van Heuven WA. Hypopyon uveitis following panretinal photocoagulation. Ophthalmic Surg Lasers 1997; 28: 505-7.

10. Kaiser RS, Trese MT. Iris atrophy, cataracts and hypotony following peripheral ablation for threshold retinopathy of prematurity. Arch Ophthalmol 2001; 119: 615-7.

11. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123: 991-9.

12. Good WV. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Early Treatment for Retinopathy of Prematurity Cooperative Group. Trans Am Ophthalmol Soc 2004; 102: 233-48.

13. Bloom SM, Mahl CF, Schiller SB. Lenticular burns following argon panretinal photocoagulation. Br J Ophthalmol 1992; 76: 630-1.

14. Kaiser RS, Trese MT. Iris atrophy, cataracts, and hypotony following peripheral ablation for threshold retinopathy of prematurity. Arch Ophthalmol 2001; 119: 615-7.

15. Lambert SR, Capone A Jr, Cingle KA, et al. Cataract and phthisis bulbi after laser photoablation for threshold retinopathy of prematurity. Am J Ophthalmol 2000; 129: 585-91.

16. Salgado CM, Celik Y, VanderVeen DK. Anterior segment complications after diode laser photocoagulation for prethreshold retinopathy of prematurity. Am J Ophthalmol 2010; 150: 6-9.

17. Irvine WD, Smiddy WE, Nicholson DH. Corneal and iris burns with the laser indirect ophthalmoscope. Am J Ophthalmol 1990; 110: 311-3.

18. Fallaha N, Lynn MJ, Aaberg TM Jr, Lambert SR. Clinical outcome of confluent laser photoablation for retinopathy of prematurity. J AAPOS 2002; 6: 81-5.

19. Trigler L, Weaver RG Jr, O’Neil JW, et al. Case series of angle-closure glaucoma after laser treatment for retinopathy of prematurity. J AAPOS 2005; 9: 17-21.

20. Uehara A, Kurokawa T, Gotoh N, et al. Angle closure glaucoma after laser photocoagulation for retinopathy of prematurity. Br J Ophthalmol 2004; 88: 1099-100.

21. Kvanta A. Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts. Curr Eye Res 1995; 14: 1015-20.



Received: 29.05.2012, revised: 9.09.2012, accepted: 18.09.2012.
Copyright: © 2012 Fundacja Videochirurgii This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.